ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 75 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 6.89 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $0 | – | 41 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 41 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 41 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | – | 41 | 0.0% | 0.00% | – |
| Q3 2016 | $0 | – | 41 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | – | 41 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | – | 41 | 0.0% | 0.00% | – |
| Q4 2015 | $0 | – | 41 | 0.0% | 0.00% | – |
| Q3 2015 | $0 | – | 41 | 0.0% | 0.00% | – |
| Q2 2015 | $0 | – | 41 | 0.0% | 0.00% | – |
| Q1 2015 | $0 | – | 41 | 0.0% | 0.00% | – |
| Q4 2014 | $0 | – | 41 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |